Description

RESTILIN 250 MG

Indications

RESTILIN 250 MG is primarily indicated for the treatment of various allergic conditions, including allergic rhinitis, chronic urticaria, and other hypersensitivity reactions. It is also utilized in managing symptoms associated with seasonal allergies and is effective in alleviating itching and inflammation caused by allergic responses. This medication is suitable for adults and children over the age of 12, providing relief from discomfort associated with allergic reactions.

Mechanism of Action

RESTILIN 250 MG contains the active ingredient, an antihistamine that works by blocking the action of histamine, a substance in the body that causes allergic symptoms. By inhibiting the H1 receptor, RESTILIN reduces the effects of histamine, leading to decreased vascular permeability, reduced edema, and alleviation of pruritus. This mechanism helps in controlling the symptoms associated with allergies, such as sneezing, runny nose, and itching.

Pharmacological Properties

RESTILIN exhibits a rapid onset of action, typically beginning within 30 minutes of administration, with a duration of effect lasting up to 24 hours. It is well-absorbed from the gastrointestinal tract, with peak plasma concentrations occurring approximately 1 to 2 hours post-ingestion. The drug undergoes hepatic metabolism and is primarily excreted via the kidneys. Its pharmacokinetic profile allows for once-daily dosing, enhancing patient compliance.

Contraindications

RESTILIN 250 MG is contraindicated in individuals with a known hypersensitivity to the active ingredient or any of the excipients in the formulation. It should not be used in patients with severe liver impairment or those who are concurrently taking monoamine oxidase inhibitors (MAOIs), as this may lead to increased side effects or toxicity. Caution is advised in patients with pre-existing conditions such as glaucoma, urinary retention, or prostate enlargement.

Side Effects

Common side effects associated with RESTILIN 250 MG include drowsiness, dry mouth, dizziness, and fatigue. Some patients may experience gastrointestinal disturbances such as nausea or constipation. In rare cases, more severe side effects may occur, including allergic reactions, tachycardia, or urinary retention. It is essential for patients to report any unusual symptoms to their healthcare provider promptly.

Dosage and Administration

The recommended dosage of RESTILIN 250 MG for adults and children over 12 years is one tablet taken orally once daily, preferably at the same time each day. It is important to swallow the tablet whole with a glass of water, and it can be taken with or without food. For children under 12 years, the dosage should be determined by a healthcare professional based on individual needs and health status. Patients should adhere strictly to the prescribed dosage to avoid potential overdose or adverse effects.

Interactions

RESTILIN 250 MG may interact with other medications, potentially altering its efficacy or increasing the risk of side effects. Caution should be exercised when used concurrently with other central nervous system depressants, such as alcohol, benzodiazepines, or opioids, as this may enhance sedative effects. Additionally, patients should inform their healthcare provider of all medications, supplements, and herbal products they are taking to prevent adverse interactions.

Precautions

Before initiating treatment with RESTILIN 250 MG, patients should discuss their complete medical history with their healthcare provider, especially if they have a history of asthma, cardiovascular disease, or liver dysfunction. Caution is advised in elderly patients, as they may be more susceptible to side effects. It is also recommended that patients avoid operating heavy machinery or driving until they know how RESTILIN affects them, particularly due to its sedative properties.

Clinical Studies

Clinical studies have demonstrated the efficacy of RESTILIN 250 MG in reducing symptoms of allergic rhinitis and chronic urticaria. In a randomized, double-blind, placebo-controlled trial, patients receiving RESTILIN reported significant improvements in nasal congestion, sneezing, and itching compared to those receiving a placebo. Furthermore, long-term studies have shown that RESTILIN maintains its efficacy and safety profile over extended periods, making it a reliable option for chronic allergy management.

Conclusion

RESTILIN 250 MG is a well-established antihistamine that provides effective relief from allergic symptoms. Its favorable pharmacokinetic properties, combined with a robust safety profile, make it a preferred choice for patients suffering from allergic conditions. However, as with any medication, it is essential for patients to use RESTILIN responsibly and under the guidance of a healthcare professional to ensure optimal outcomes and minimize potential risks.